Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
absorb, ancillary, avoid, award, biomarker, biotechnology, burden, capability, caption, captioned, categorized, commenced, composition, concept, conserve, Contemporaneously, correction, credibility, diversify, earlier, environment, error, fee, flagship, front, fueled, GLP, guidance, hematology, HPLC, impracticable, inherited, intermediate, Issuer, largest, laying, lengthy, maintenance, medicine, mitigate, modular, momentum, multiple, newest, newly, nonmonetary, notification, Oppenheimer, outsourcing, oven, overstocked, patient, platform, predict, progression, prove, proven, representation, repricing, retrospective, SEC, sensitivity, sequential, steadily, straight, substance, suite, summarized, taxable, therapy, thinly, unchanged, unrelated, usability, version, write
Removed:
acceptable, admitted, American, amino, April, assist, Biochemistry, block, center, central, chemistry, collaboration, College, Commission, commitment, competency, conform, Counsel, department, drug, embodied, encountered, enhancement, enzymology, executed, experimental, expertise, expiration, extensively, fluorescent, focusing, forma, formulated, fully, gel, gene, half, impacted, impacting, improve, improved, incorporation, increasingly, insufficient, Integra, intense, internet, Japan, Jersey, Johnson, June, Kalamazoo, Keith, launched, level, link, location, main, managed, manipulation, member, Michigan, modify, movement, NJ, North, partner, Pierce, Plainsboro, plant, powerful, pro, producing, profitable, Proligo, reaction, recently, reclassification, reviewed, Rim, RNA, satisfy, Senior, separating, sequence, shifted, space, strategically, supplemental, synthesized, synthetic, thereto, tracked, varying, viable, Washington
Filing tables
Filing exhibits
- 10-K Annual report
- 10.34 Common Stock Purchase
- 10.35 Letter Agreement Dated September 22, 2005
- 10.36 Letter Agreement Dated October 31, 2005
- 21 Subsidiaries of the Registrant
- 23 Consent of Independent Registered Public Accounting Firm
- 24 Powers of Attorney
- 31 Section 302 CEO and CFO Certification
- 32 Section 906 CEO and CFO Certification
Related press release
PRPO similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-41714, No. 333-69334 and No. 333-71866 on Forms S-8 and Registration Statement No. 333-70102, No. 333-108319, No. 333-111442, No. 333-114661 and No. 333-118970 on Form S-3 of our report dated March 30, 2006 relating to the consolidated financial statements of Transgenomic, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of Transgenomic, Inc. for the year ended December 31, 2005.
/s/ Deloitte & Touche LLP |
Omaha, Nebraska |
March 30, 2006 |